| A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease M Björkqvist, EJ Wild, J Thiele, A Silvestroni, R Andre, N Lahiri, ... The Journal of experimental medicine 205 (8), 1869-1877, 2008 | 734 | 2008 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 434 | 2012 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 312 | 2017 |
| Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease PM Gaughwin, M Ciesla, N Lahiri, SJ Tabrizi, P Brundin, M Björkqvist Human molecular genetics 20 (11), 2225-2237, 2011 | 215 | 2011 |
| HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation U Träger, R Andre, N Lahiri, A Magnusson-Lind, A Weiss, S Grueninger, ... Brain 137 (3), 819-833, 2014 | 184 | 2014 |
| Tapping linked to function and structure in premanifest and symptomatic Huntington disease N Bechtel, RI Scahill, HD Rosas, T Acharya, SJA van den Bogaard, ... Neurology 75 (24), 2150-2160, 2010 | 173 | 2010 |
| Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression A Weiss, U Träger, EJ Wild, S Grueninger, R Farmer, C Landles, ... The Journal of clinical investigation 122 (10), 3731-3736, 2012 | 165 | 2012 |
| Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers M Politis, N Lahiri, F Niccolini, P Su, K Wu, P Giannetti, RI Scahill, ... Neurobiology of disease 83, 115-121, 2015 | 156 | 2015 |
| MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1 M Flower, V Lomeikaite, M Ciosi, S Cumming, F Morales, K Lo, ... Brain 142 (7), 1876-1886, 2019 | 150 | 2019 |
| Brain-derived neurotrophic factor in patients with Huntington's disease C Zuccato, M Marullo, B Vitali, A Tarditi, C Mariotti, M Valenza, N Lahiri, ... PLoS One 6 (8), e22966, 2011 | 150 | 2011 |
| A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease K Bečanović, A Nørremølle, SJ Neal, C Kay, JA Collins, D Arenillas, T Lilja, ... Nature neuroscience 18 (6), 807-816, 2015 | 143 | 2015 |
| Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy RI Scahill, NZ Hobbs, MJ Say, N Bechtel, SMD Henley, H Hyare, ... Human brain mapping 34 (3), 519-529, 2013 | 142 | 2013 |
| Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease NA Aziz, CK Jurgens, GB Landwehrmeyer, EHDN Registry Study Group, ... Neurology 73 (16), 1280-1285, 2009 | 131 | 2009 |
| Abnormal peripheral chemokine profile in Huntington’s disease E Wild, A Magnusson, N Lahiri, U Krus, M Orth, SJ Tabrizi, M Björkqvist PLoS currents 3, 2011 | 124 | 2011 |
| Suicidal ideation in a European Huntington's disease population AAM Hubers, E Van Duijn, RAC Roos, D Craufurd, H Rickards, ... Journal of affective disorders 151 (1), 248-258, 2013 | 105 | 2013 |
| The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease P Soman, A Parsons, N Lahiri, A Lahiri Journal of Nuclear Cardiology 6 (3), 252-256, 1999 | 95 | 1999 |
| Diagnostic genetic testing for Huntington's disease D Craufurd, R MacLeod, M Frontali, O Quarrell, EK Bijlsma, M Davis, ... Practical neurology 15 (1), 80-84, 2015 | 83 | 2015 |
| The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease EB Johnson, EM Rees, I Labuschagne, A Durr, BR Leavitt, RAC Roos, ... Neuropsychologia 79, 138-146, 2015 | 69 | 2015 |
| Assessment of involuntary choreatic movements in Huntington's disease—toward objective and quantitative measures R Reilmann, S Bohlen, F Kirsten, EB Ringelstein, HW Lange Movement disorders 26 (12), 2267-2273, 2011 | 64 | 2011 |
| Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease R Reilmann, S Bohlen, T Klopstock, A Bender, A Weindl, P Saemann, ... Movement disorders 25 (13), 2195-2202, 2010 | 64 | 2010 |
